The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide
- collapse Pan-European Survey on the Under Treatment of Hypercholesterolemia
- collapse An observational study into the usage and efficacy of Crestor 5mg as a start dosage in achieving the LDL-C target level in both statin-naive and treated primary and secondary prevention patients with a high risk of a cardiovascular event.
- collapse DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
- collapse Crestor RAPID (The efficacy of RosuvAstatin for korean dyslipidemia PatIents with Diabetes)
- collapse Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal
- collapse SA-NXY-0013 Effects of cimetidine and probenecid on NXY-059
- collapse CHANT (Cerebral Hemorrhage And NXY Treatment) A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase IIb study to assess the safety and tolerability of 72 hours intravenous infusion of NXY-059 in adult patients with acute intracerebral hemorrhge (ICH)
- collapse Interaction between NXY-059 and furosemide? A PK/PD study of intravenous doses of the two drugs to healthy volunteers.
- collapse A single-center phase I study in healthy, male volunteers, consisting of two separate randomized, double-blind, placebo controlled three-period cross-over sessions assessing the effect of NXY-059 (8 h i.v. infusion) on bleeding time, platelet aggregation and platelet adhesion as compared with that of desmopressin (10 min i.v. injection) and ASA (160 mg o.d. for three days) respectively
